Cargando…

Predictive study of pharmacological reversal for residual neuromuscular blockade and postoperative pulmonary complications: a prospective, observational, cohort study

In recent years, some studies have generated controversy since they conclude that intraoperatively pharmacological reversal of neuromuscular blockade does not contribute to the reduction of postoperative residual neuromuscular blockade or pulmonary complications. Therefore, the main objective of thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aragón-Benedí, Cristian, Pascual-Bellosta, Ana, Ortega-Lucea, Sonia, Visiedo-Sánchez, Sara, Martínez-Ubieto, Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440015/ https://www.ncbi.nlm.nih.gov/pubmed/36056061 http://dx.doi.org/10.1038/s41598-022-18917-y

Ejemplares similares

Model for predicting early and late-onset postoperative pulmonary complications in perioperative patients receiving neuromuscular blockade: a secondary analysis
por: Aragón-Benedí, Cristian, et al.
Publicado: (2023)

Neuromonitoring depth of anesthesia and its association with postoperative delirium
por: Pérez-Otal, Berta, et al.
Publicado: (2022)

Economic impact of improving patient safety using Sugammadex for routine reversal of neuromuscular blockade in Spain
por: Martinez-Ubieto, J., et al.
Publicado: (2021)

Usefulness of intra-operative neuromuscular blockade monitoring and reversal agents for postoperative residual neuromuscular blockade: a retrospective observational study
por: Domenech, Gonzalo, et al.
Publicado: (2019)

Analysis of the postoperative hemostatic profile of colorectal cancer patients subjected to liver metastasis resection surgery
por: Perez Navarro, Guillermo, et al.
Publicado: (2019)

Laparoscopic surgery in 3D improves results and surgeon convenience in sleeve gastrectomy for morbid obesity
por: Martínez-Ubieto, Fernando, et al.
Publicado: (2022)

Introduction of sugammadex as standard reversal agent: Impact on the incidence of residual neuromuscular blockade and postoperative patient outcome
por: Ledowski, Thomas, et al.
Publicado: (2013)

The efficacy and safety of sugammadex for reversing postoperative residual neuromuscular blockade in pediatric patients: A systematic review
por: Liu, Guangyu, et al.
Publicado: (2017)

Residual Neuromuscular Blockade and Postoperative Pulmonary Complications: What Does the Recent Evidence Demonstrate?
por: Cammu, Guy
Publicado: (2020)

Observational study on patterns of neuromuscular blockade reversal
por: Dubovoy, Timur, et al.
Publicado: (2016)

Incidence of postoperative residual neuromuscular blockade − A multicenter, observational study in Portugal (INSPIRE 2)
por: Esteves, Simão, et al.
Publicado: (2023)

Residual neuromuscular blockade and late neuromuscular blockade at the post-anesthetic recovery unit: prospective cohort study
por: Gonçalves, Pedro Marcos Silva e, et al.
Publicado: (2020)

Clinical Impact of Sugammadex in the Reversal of Neuromuscular Blockade
por: Goodner, Joshua A, et al.
Publicado: (2021)

The Effect of Neuromuscular Blockade Reversal Agents on Postoperative Pulmonary Complications in Patients undergoing Femur Fracture Repair Surgery: A Retrospective Observational Study
por: Cho, Sung-Ae, et al.
Publicado: (2023)

Quantitative Relationships between Pulmonary Function and Residual Neuromuscular Blockade
por: Fu, ShuYing, et al.
Publicado: (2018)

Postoperative pulmonary complications after sugammadex reversal of neuromuscular blockade: a systematic review and meta-analysis with trial sequential analysis
por: Liu, Hong-Mei, et al.
Publicado: (2023)

Profile of sugammadex for reversal of neuromuscular blockade in the elderly: current perspectives
por: Carron, Michele, et al.
Publicado: (2017)

Asystole Following Neuromuscular Blockade Reversal in Cardiac Transplant Patients
por: Nkemngu, Njinkeng J
Publicado: (2017)

Reevaluation and update on efficacy and safety of neostigmine for reversal of neuromuscular blockade
por: Luo, Jie, et al.
Publicado: (2018)

Improving Neuromuscular Monitoring and Reducing Residual Neuromuscular Blockade With E-Learning: Protocol for the Multicenter Interrupted Time Series INVERT Study
por: Thomsen, Jakob Louis Demant, et al.
Publicado: (2017)

Improving neuromuscular monitoring and reducing residual neuromuscular blockade via e‐learning: A multicentre interrupted time‐series study (INVERT study)
por: Thomsen, Jakob Louis Demant, et al.
Publicado: (2022)

Choice of neuromuscular block reversal agent to reduce postoperative pulmonary complications
por: Cho, Sung-Ae, et al.
Publicado: (2022)

Recurrent intestinal intussusception in an adult due to intestinal pseudopolyps not associated with inflammatory bowel disease: a case report
por: Martínez-Ubieto, Fernando, et al.
Publicado: (2015)

Reversing Neuromuscular Blockade without Nerve Stimulator Guidance in a Postsurgical ICU—An Observational Study
por: Calef, Andrea, et al.
Publicado: (2023)

The association between residual neuromuscular blockade (RNMB) and critical respiratory events: a prospective cohort study
por: Alenezi, Faraj K, et al.
Publicado: (2021)

Neuromuscular blockade reversal with sugammadex versus pyridostigmine/glycopyrrolate in laparoscopic cholecystectomy: a randomized trial of effects on postoperative gastrointestinal motility
por: An, Jihyun, et al.
Publicado: (2020)

Qualitative Neuromuscular Monitoring: How to Optimize the Use of a Peripheral Nerve Stimulator to Reduce the Risk of Residual Neuromuscular Blockade
por: Thilen, Stephan R., et al.
Publicado: (2016)

Postoperative Residual Neuromuscular Paralysis at an Australian Tertiary Children's Hospital
por: Ledowski, Thomas, et al.
Publicado: (2015)

Neuromuscular Blockade Agents Reversal with Sugammadex Compared to Neostigmine in the Living Kidney Donors
por: Quang, Thuy Luu, et al.
Publicado: (2019)

Neuromuscular Blockade and Reversal Agent Practice Variability in the US Inpatient Surgical Settings
por: Bash, Lori D., et al.
Publicado: (2021)

Management of Residual Neuromuscular Blockade Recovery: Age-Old Problem with a New Solution
por: Green, Michael S., et al.
Publicado: (2017)

A retrospective study of sugammadex for reversal of neuromuscular blockade induced by rocuronium in critically ill patients in the ICU
por: Bologheanu, Răzvan, et al.
Publicado: (2022)

Postoperative negative pressure pulmonary edema following repetitive laryngospasm even after reversal of neuromuscular blockade by sugammadex: a case report
por: Lee, Ji Hyeon, et al.
Publicado: (2017)

Neuromuscular blockade in the elderly patient
por: Lee, Luis A, et al.
Publicado: (2016)

Intraoperative Monitoring of Neuromuscular Blockade
por: Motamed, Cyrus
Publicado: (2023)

Negative Pressure Pulmonary Edema after Reversing Rocuronium-Induced Neuromuscular Blockade by Sugammadex
por: Suzuki, Manzo, et al.
Publicado: (2014)

Sugammadex, a Neuromuscular Blockade Reversal Agent, Causes Neuronal Apoptosis in Primary Cultures
por: Palanca, José M., et al.
Publicado: (2013)

Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in Korean patients
por: Woo, Tiffany, et al.
Publicado: (2013)

Sugammadex to Reverse Neuromuscular Blockade in a Child with a Past History of Cardiac Transplantation
por: Miller, Karen, et al.
Publicado: (2017)

Sugammadex to reverse neuromuscular blockade and provide optimal conditions for motor-evoked potential monitoring
por: Trifa, Mehdi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vc91j1bbp09p27o6mufq8uhr63